A detailed history of Royal Bank Of Canada transactions in Senseonics Holdings, Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 89,930 shares of SENS stock, worth $26,979. This represents 0.0% of its overall portfolio holdings.

Number of Shares
89,930
Previous 89,190 0.83%
Holding current value
$26,979
Previous $35,000 11.43%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$0.32 - $0.49 $236 - $362
740 Added 0.83%
89,930 $31,000
Q2 2024

Aug 14, 2024

SELL
$0.37 - $0.52 $1,126 - $1,583
-3,045 Reduced 3.3%
89,190 $35,000
Q1 2024

Nov 05, 2024

BUY
$0.5 - $0.73 $1,522 - $2,222
3,045 Added 3.41%
92,235 $48,000
Q1 2024

May 15, 2024

BUY
$0.5 - $0.73 $3,042 - $4,442
6,085 Added 7.06%
92,235 $48,000
Q4 2023

Feb 14, 2024

BUY
$0.48 - $0.7 $5,193 - $7,573
10,820 Added 14.36%
86,150 $49,000
Q3 2023

Nov 14, 2023

SELL
$0.5 - $1.05 $2,489 - $5,227
-4,979 Reduced 6.2%
75,330 $45,000
Q2 2023

Aug 14, 2023

SELL
$0.55 - $0.89 $14,208 - $22,992
-25,834 Reduced 24.34%
80,309 $61,000
Q1 2023

May 15, 2023

SELL
$0.68 - $1.25 $29,712 - $54,618
-43,695 Reduced 29.16%
106,143 $75,000
Q4 2022

Feb 14, 2023

BUY
$0.96 - $1.34 $64,104 - $89,478
66,775 Added 80.39%
149,838 $154,000
Q3 2022

Nov 14, 2022

BUY
$1.02 - $2.23 $2,832 - $6,192
2,777 Added 3.46%
83,063 $109,000
Q2 2022

Aug 15, 2022

SELL
$0.94 - $1.94 $21,195 - $43,743
-22,548 Reduced 21.93%
80,286 $83,000
Q1 2022

May 16, 2022

SELL
$1.54 - $3.71 $136,433 - $328,680
-88,593 Reduced 46.28%
102,834 $202,000
Q4 2021

Feb 14, 2022

BUY
$2.58 - $3.91 $175,269 - $265,621
67,934 Added 55.01%
191,427 $511,000
Q3 2021

Nov 15, 2021

BUY
$2.77 - $4.05 $40,707 - $59,518
14,696 Added 13.51%
123,493 $419,000
Q2 2021

Aug 16, 2021

BUY
$1.71 - $4.14 $186,042 - $450,419
108,797 New
108,797 $417,000

Others Institutions Holding SENS

About Senseonics Holdings, Inc.


  • Ticker SENS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 465,447,008
  • Market Cap $140M
  • Description
  • Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with ...
More about SENS
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.